Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dipexium Pharmaceuticals, LLC | 109,309 | reported | 18 Mar 2014 | tx 1+2,083 |
| INTERPUBLIC GROUP OF COMPANIES, INC. | 106,685 | reported | 18 May 2004 | tx 2+160,027 |
| Johnson Controls International plc | 88,558 | reported | 26 Nov 2010 | tx 47+1,831,903−211,546 |
| CENTENE CORP | 18,148.926 | reported | 12 May 2026 | tx 27+58,202.95−878 |
| Actavis plc | 16,542 | reported | 08 May 2020 | tx 43+46,574−65,610 |
| DUN & BRADSTREET CORP/NW | 16,535.91 | reported | 10 Mar 2017 | tx 136+69,035.9−15,384 |
| Prestige Consumer Healthcare Inc. | 13,218 | reported | 02 Aug 2022 | tx 4+13,218 |
| HOLOGIC INC | 6,816 | reported | 08 Mar 2017 | tx 6+21,278−2,427 |
| Covidien Ltd. | 0 | reported | 26 Jan 2015 | tx 60+103,634−326,382 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 21 Jul 2021 | tx 21+49,690−49,690 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | GRANT_AWARD | CENTENE CORP | 3,992 | 0.00 USD | |
| 31 Mar 2026 | GRANT_AWARD | CENTENE CORP | 1,140 | 0.00 USD | |
| 31 Dec 2025 | GRANT_AWARD | CENTENE CORP | 729 | 0.00 USD | |
| 30 Sept 2025 | GRANT_AWARD | CENTENE CORP | 852 | 0.00 USD | |
| 30 Jun 2025 | GRANT_AWARD | CENTENE CORP | 556 | 0.00 USD | |
| 13 May 2025 | GRANT_AWARD | CENTENE CORP | 3,579 | 0.00 USD | |
| 31 Mar 2025 | GRANT_AWARD | CENTENE CORP | 500 | 0.00 USD | |
| 31 Dec 2024 | GRANT_AWARD | CENTENE CORP | 497 | 0.00 USD | |
| 16 Dec 2024 | PURCHASE | CENTENE CORP | 10,000 | 59.44 USD | first after silence |
| 30 Sept 2024 | GRANT_AWARD | CENTENE CORP | 402 | 0.00 USD | |
| 30 Jun 2024 | GRANT_AWARD | CENTENE CORP | 452 | 0.00 USD | |
| 14 May 2024 | SALE | CENTENE CORP | 878 | 76.75 USD | |
| 14 May 2024 | GRANT_AWARD | CENTENE CORP | 2,916 | 0.00 USD | |
| 31 Mar 2024 | GRANT_AWARD | CENTENE CORP | 388.55 | 0.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 990 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 1,904 | 92.30 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 976 | 136.81 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 5,000 | 227.04 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 25,000 | 243.35 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 8,500 | 201.99 USD | deriv |
| 31 Dec 2023 | GRANT_AWARD | CENTENE CORP | 502.5 | 0.00 USD | |
| 30 Sept 2023 | GRANT_AWARD | CENTENE CORP | 544.87 | 0.00 USD | |
| 30 Jun 2023 | GRANT_AWARD | CENTENE CORP | 543.56 | 0.00 USD | |
| 20 Jun 2023 | GRANT_AWARD | Karuna Therapeutics, Inc. | 990 | 0.00 USD | |
| 20 Jun 2023 | GRANT_AWARD | Karuna Therapeutics, Inc. | 1,904 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 16 Dec 2024.